Security Alert

Beware of fraudulent messages impersonating amana.

We have been made aware of fraudulent emails, messages, and job offers circulating online from individuals falsely claiming to represent amana.

These scams may promise investment opportunities, employment, or financial rewards while requesting personal information, payments, or account details.

Please note that the only official amana website is
www.amana.app

Please also be aware of the following fraudulent domains impersonating amana:

amanacapital961
amana.live
getamana.com
client.amana-trade.com
amanatrade.net
amana-capital.net
amaanahcapitall.com

logo

Deposit $200 to get a $100 trading bonus.

Use the promo code AMANAWEB.

Sign up now.*T&Cs Apply.

Terms & Conditions

  1. Offer valid for new users signing up on amana.
  2. How to Qualify for $100 Trading Bonus:
    • Sign up via the website.
    • Complete onboarding by providing the required details.
    • Enter promo code AMANAWEB at the final step.
    • Deposit $100 or more before your first trade.
    • Make your first trade.
  3. Once all steps are completed, you’ll receive a $100 non-withdrawable trading bonus.
  4. Bonuses are credited during the first week of every month.
  5. The bonus can only be used for trading and cannot be withdrawn.
  6. The campaign is exclusive to selected amana customers.
  7. amana reserves the right to cancel bonuses in cases of suspected fraud.
TSHA icon

TSHA

4.32 USD

-0.47%

Today

+3.93%

1D

Market is closed

Sun

Closed

Mon

4:30 PM ~ 10:59 PM

Tue

4:30 PM ~ 10:59 PM

Wed

4:30 PM ~ 10:59 PM

Thu

4:30 PM ~ 10:59 PM

Fri

4:30 PM ~ 10:59 PM

Sat

Closed

Loading chart...
1D
5D
1M
3M
1Y
MAX

Information

Name

Taysha Gene Therapies

Currency

USD

Market Cap

1.33B

Avg Daily Volume

3.54M

52 Week High

7.3 USD

52 Week Low

3.455 USD

Trading Hours

See hours

Business Summary

Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central nervous system. The company primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; and TSHA-114 for the treatment of fragile X syndrome. The company has research, collaboration, and license agreement with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.

Top News

Taysha.Gene

+10.79%

Taysha Gene Therapies (TSHA) Stock Looks Rich Against Book Value

finance.yahoo.com

5d ago

No Image

Taysha.Gene

+10.79%

Does Early Rett Trial Success Change The Bull Case For Taysha Gene Therapies (TSHA)?

finance.yahoo.com

2w ago

No Image

Taysha.Gene

+10.79%

Taysha Gene Therapies (TSHA) Stock May Be Above Fair Value On Book Value

finance.yahoo.com

3w ago

No Image

Show more

Frequently Asked Questions

What are healthcare stocks and why are they important to investors?

Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.

Are healthcare stocks less volatile?

Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.

What drives growth in healthcare investments?

Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.

What are the risks of investing in healthcare?

Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.